These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 31099946)

  • 41. Design and Clinical Evaluation of the Interoperable Artificial Pancreas System (iAPS) Smartphone App: Interoperable Components with Modular Design for Progressive Artificial Pancreas Research and Development.
    Deshpande S; Pinsker JE; Zavitsanou S; Shi D; Tompot R; Church MM; Andre C; Doyle FJ; Dassau E
    Diabetes Technol Ther; 2019 Jan; 21(1):35-43. PubMed ID: 30547670
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Application of Zone Model Predictive Control Artificial Pancreas During Extended Use of Infusion Set and Sensor: A Randomized Crossover-Controlled Home-Use Trial.
    Forlenza GP; Deshpande S; Ly TT; Howsmon DP; Cameron F; Baysal N; Mauritzen E; Marcal T; Towers L; Bequette BW; Huyett LM; Pinsker JE; Gondhalekar R; Doyle FJ; Maahs DM; Buckingham BA; Dassau E
    Diabetes Care; 2017 Aug; 40(8):1096-1102. PubMed ID: 28584075
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optimal predictive low glucose management settings during physical exercise in adolescents with type 1 diabetes.
    Cherubini V; Gesuita R; Skrami E; Rabbone I; Bonfanti R; Arnaldi C; D'Annunzio G; Frongia A; Lombardo F; Piccinno E; Schiaffini R; Toni S; Tumini S; Tinti D; Cipriano P; Minuto N; Lenzi L; Ferrito L; Ventrici C; Ortolani F; Cohen O; Scaramuzza A
    Pediatr Diabetes; 2019 Feb; 20(1):107-112. PubMed ID: 30378759
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of an Artificial Pancreas with Enhanced Model Predictive Control and a Glucose Prediction Trust Index with Unannounced Exercise.
    Pinsker JE; Laguna Sanz AJ; Lee JB; Church MM; Andre C; Lindsey LE; Doyle FJ; Dassau E
    Diabetes Technol Ther; 2018 Jul; 20(7):455-464. PubMed ID: 29958023
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effectiveness of artificial pancreas in the non-adult population: A systematic review and network meta-analysis.
    Karageorgiou V; Papaioannou TG; Bellos I; Alexandraki K; Tentolouris N; Stefanadis C; Chrousos GP; Tousoulis D
    Metabolism; 2019 Jan; 90():20-30. PubMed ID: 30321535
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Individual glucose responses to prolonged moderate intensity aerobic exercise in adolescents with type 1 diabetes: The higher they start, the harder they fall.
    Riddell MC; Zaharieva DP; Tansey M; Tsalikian E; Admon G; Li Z; Kollman C; Beck RW
    Pediatr Diabetes; 2019 Feb; 20(1):99-106. PubMed ID: 30467929
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of predicted low suspend pump treatment on improving glycaemic control and quality of sleep in children with type 1 diabetes and their caregivers: the QUEST randomized crossover study.
    Schierloh U; Aguayo GA; Fichelle M; De Melo Dias C; Celebic A; Vaillant M; Barnard K; Cohen O; de Beaufort C
    Trials; 2018 Dec; 19(1):665. PubMed ID: 30509293
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MD-Logic overnight type 1 diabetes control in home settings: A multicentre, multinational, single blind randomized trial.
    Nimri R; Bratina N; Kordonouri O; Avbelj Stefanija M; Fath M; Biester T; Muller I; Atlas E; Miller S; Fogel A; Phillip M; Danne T; Battelino T
    Diabetes Obes Metab; 2017 Apr; 19(4):553-561. PubMed ID: 27981804
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety and Performance of the Tandem t:slim X2 with Control-IQ Automated Insulin Delivery System in Toddlers and Preschoolers.
    Ekhlaspour L; Schoelwer MJ; Forlenza GP; DeBoer MD; Norlander L; Hsu L; Kingman R; Boranian E; Berget C; Emory E; Buckingham BA; Breton MD; Wadwa RP
    Diabetes Technol Ther; 2021 May; 23(5):384-391. PubMed ID: 33226837
    [No Abstract]   [Full Text] [Related]  

  • 51. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.
    Rodbard D
    Diabetes Technol Ther; 2017 Jun; 19(S3):S25-S37. PubMed ID: 28585879
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MD-Logic overnight control for 6 weeks of home use in patients with type 1 diabetes: randomized crossover trial.
    Nimri R; Muller I; Atlas E; Miller S; Fogel A; Bratina N; Kordonouri O; Battelino T; Danne T; Phillip M
    Diabetes Care; 2014 Nov; 37(11):3025-32. PubMed ID: 25078901
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial.
    Haidar A; Legault L; Matteau-Pelletier L; Messier V; Dallaire M; Ladouceur M; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2015 Aug; 3(8):595-604. PubMed ID: 26066705
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Artificial Pancreas Technology Offers Hope for Childhood Diabetes.
    Schoelwer MJ; DeBoer MD
    Curr Nutr Rep; 2021 Mar; 10(1):47-57. PubMed ID: 33411096
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
    Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
    Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Automated Overnight Closed-Loop Control Using a Proportional-Integral-Derivative Algorithm with Insulin Feedback in Children and Adolescents with Type 1 Diabetes at Diabetes Camp.
    Ly TT; Keenan DB; Roy A; Han J; Grosman B; Cantwell M; Kurtz N; von Eyben R; Clinton P; Wilson DM; Buckingham BA
    Diabetes Technol Ther; 2016 Jun; 18(6):377-84. PubMed ID: 27183197
    [TBL] [Abstract][Full Text] [Related]  

  • 57. "Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients.
    Biester T; Kordonouri O; Holder M; Remus K; Kieninger-Baum D; Wadien T; Danne T
    Diabetes Technol Ther; 2017 Mar; 19(3):173-182. PubMed ID: 28099035
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Automatic data processing to achieve a safe telemedical artificial pancreas.
    Hernando ME; García-Sáez G; Martínez-Sarriegui I; Rodríguez-Herrero A; Pérez-Gandía C; Rigla M; de Leiva A; Capel I; Pons B; Gómez EJ
    J Diabetes Sci Technol; 2009 Sep; 3(5):1039-46. PubMed ID: 20144417
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fully Closed-Loop Multiple Model Probabilistic Predictive Controller Artificial Pancreas Performance in Adolescents and Adults in a Supervised Hotel Setting.
    Forlenza GP; Cameron FM; Ly TT; Lam D; Howsmon DP; Baysal N; Kulina G; Messer L; Clinton P; Levister C; Patek SD; Levy CJ; Wadwa RP; Maahs DM; Bequette BW; Buckingham BA
    Diabetes Technol Ther; 2018 May; 20(5):335-343. PubMed ID: 29658779
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Perioperative Considerations for Evolving Artificial Pancreas Devices.
    Long MT; Coursin DB; Rice MJ
    Anesth Analg; 2019 May; 128(5):902-906. PubMed ID: 30198923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.